IPSEN BIOPHARM LIMITED
Operating as a UK subsidiary of the Euronext Paris-listed French group Ipsen, the company manufactures basic pharmaceutical products and holds the registered trademarks for medicines such as Dysport and Onivyde.
Get an alert when IPSEN BIOPHARM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£588m
-4.6% lowest in 3 filed years
Employees
773
+8.4% highest in 3 filed years
Profit before tax
£209m
-2.1% lowest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £661,765,000 | £685,409,000 | £697,406,000 | +1.8% | |
| Operating profit | £322,346,000 | £197,946,000 | £202,597,000 | +2.3% | |
| Profit before tax | £340,412,000 | £213,228,000 | £208,654,000 | -2.1% | |
| Net profit | £259,040,000 | £159,492,000 | £156,965,000 | -1.6% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | £842,947,000 | £696,720,000 | £661,450,000 | -5.1% | |
| Net assets | £763,853,000 | £616,862,000 | £588,218,000 | -4.6% | |
| Equity | £763,853,000 | £616,862,000 | £588,218,000 | -4.6% | |
| Average employees | 701 | 713 | 773 | +8.4% | |
| Wages | £58,360,000 | £67,279,000 | £72,497,000 | +7.8% | |
| Directors' remuneration | £818,000 | £925,000 | £936,000 | +1.2% | |
| Directors' pension contributions | £96,000 | £116,000 | £116,000 | 0% | |
| Highest paid director | £358,000 | £379,000 | £361,000 | -4.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 48.7% | 28.9% | 29.1% | |
| Net margin | 39.1% | 23.3% | 22.5% | |
| Return on capital employed | 38.2% | 28.4% | 30.6% | |
| Gearing (liabilities / total assets) | 22.4% | 39.1% | 37.2% | |
| Current ratio | 4.28x | 1.65x | 1.69x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 3 times since incorporation
- IPSEN BIOPHARM LIMITED 2001-11-21 → present
- SPEYWOOD GROUP LIMITED 1995-01-16 → 2001-11-21
- PORTON INTERNATIONAL PLC 1984-01-27 → 1995-01-16
- ALARBROOK LIMITED 1982-07-23 → 1984-01-27
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”
Group structure
- IPSEN BIOPHARM LIMITED · parent
- Ipsen Pty Limited 100%
- Pothold Limited 100%
- Specwood Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 52 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MILLAR-KELLY, Lynne Elizabeth Duncan | Secretary | 2022-03-16 | — | — |
| BREND, Jeannette | Director | 2022-11-01 | Nov 1971 | British |
| CHADDOCK, John Andrew, Dr | Director | 2016-11-18 | Aug 1968 | British |
| MILLAR-KELLY, Lynne Elizabeth Duncan | Director | 2022-03-16 | Aug 1983 | British |
| PARSONS, Ioana | Director | 2024-03-08 | Feb 1979 | Romanian,British |
| VISCIGLIO, Alexandre | Director | 2021-05-28 | Jan 1979 | French |
Show 52 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOOTH, Edward Andrew | Secretary | 2013-07-01 | 2015-04-30 |
| BUSBY, Robyn Elizabeth | Secretary | 2018-05-31 | 2018-10-11 |
| DAVIS, John Charles | Secretary | — | 2013-06-30 |
| LAMB, Catherine | Secretary | 2018-10-11 | 2020-10-15 |
| MILLAR, Lynne | Secretary | 2020-10-15 | 2021-05-28 |
| PULLEN, Jane Elizabeth | Secretary | 2015-04-30 | 2018-05-31 |
| TOMKINSON, Re-Natta | Secretary | 2021-05-28 | 2022-03-16 |
| ALI, Asad Mohsin | Director | 2018-10-15 | 2022-03-16 |
| ALLSOP, Judith Mary | Director | 2015-03-31 | 2018-05-01 |
| BARNSLEY, Jonathan Henry | Director | 2014-08-27 | 2017-12-22 |
| BEAUFOUR, Albert Henri, Dr | Director | 1994-12-12 | 2000-01-28 |
| BEAUFOUR, Philippe Henri | Director | 1994-12-12 | 1998-12-17 |
| BOOTH, Edward Andrew | Director | 2013-07-01 | 2016-02-11 |
| BOYNE, Isobel Louise | Director | 2018-03-27 | 2021-05-28 |
| BURKE, John Vernon | Director | — | 1993-07-15 |
| BUSBY, Robyn Elizabeth | Director | 2016-11-18 | 2018-10-11 |
| CANAL, Christophe Alain Edmond Georges | Director | 2007-08-01 | 2008-12-12 |
| CHILVER, Amos Henry, Lord | Director | 1995-02-01 | 2001-10-24 |
| CHILVER, Amos Henry, Lord | Director | — | 1994-11-30 |
| DAFOUR, Gabriel | Director | 1994-12-12 | 2001-12-26 |
| DAVIS, John Charles | Director | 2001-11-15 | 2013-06-30 |
| DAVIS, Nicholas Edward | Director | 2017-12-08 | 2020-11-30 |
| DE LA TOUR, Christian | Director | 2001-11-15 | 2014-11-25 |
| DRAPE, Eric | Director | 2007-07-25 | 2013-07-26 |
| FRANCOIS, Stephane | Director | 1994-12-12 | 2004-04-01 |
| GOVER, Anthony David | Director | — | 2001-12-14 |
| GROSSART, Angus Mcfarlane Mcleod, Sir | Director | 1995-02-01 | 2001-10-24 |
| GROSSART, Angus Mcfarlane Mcleod, Sir | Director | — | 1994-11-30 |
| HARSANYI, Zsolt, Doctor | Director | — | 2001-12-17 |
| HARVEY, Michael John | Director | 2004-03-03 | 2010-09-30 |
| HAYDON-BAILLIE, Wensley Grosvenor | Director | — | 1992-07-03 |
| HICKLING, Matthew Francis, Dr | Director | 2016-03-01 | 2018-05-02 |
| HILL, Steven Thomas | Director | 2007-06-27 | 2009-12-03 |
| JOCHEM, Olivier | Director | 2015-03-31 | 2016-02-10 |
| KRIEGER, Matthias, Dr | Director | 2021-04-27 | 2022-07-11 |
| LAMB, Catherine Anne | Director | 2018-10-15 | 2020-10-30 |
| LAUNAY, Nicole Bernadette | Director | 2015-03-31 | 2018-05-02 |
| MCDOWALL, Ewan John | Director | 2016-11-18 | 2018-10-11 |
| MILLAR, Lynne | Director | 2020-10-15 | 2021-05-28 |
| MURPHY, Aidan Gerard, Dr | Director | 2015-03-31 | 2018-01-01 |
| OLIVER, Guy Edward | Director | 2022-04-25 | 2024-03-08 |
| PADGETT, Robert Alan | Director | 1993-08-18 | 1994-11-30 |
| PULLEN, Jane Elizabeth | Director | 2016-02-11 | 2017-06-13 |
| PURTON, Peter John | Director | 1993-08-18 | 1994-11-30 |
| SAVAGE, John William | Director | 2001-11-15 | 2004-06-23 |
| SEMERJIAN, Harout | Director | 2017-12-08 | 2018-05-02 |
| SHEDDEN, William Ian Hamilton, Doctor | Director | 1994-12-12 | 1998-01-01 |
| STOKES, Alistair Michael, Dr | Director | 1992-05-27 | 2009-12-31 |
| STRATTON, Anthony Hugh | Director | 2017-06-13 | 2018-03-28 |
| TOMKINSON, Re-Natta Dominica | Director | 2021-05-28 | 2022-03-16 |
| WHITEHOUSE, Peter George | Director | 2005-10-07 | 2007-04-04 |
| WILSON, Peter Charles | Director | 2001-11-15 | 2007-06-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ipsen Developments Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 276 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-04-11 RESOLUTIONS Resolution
- 2023-04-11 MA Memorandum articles
- 2023-03-30 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-10-02 | AA | accounts | Accounts with accounts type full | |
| 2026-03-06 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2025-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-13 | AA | accounts | Accounts with accounts type full | |
| 2024-10-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-01 | CH01 | officers | Change person director company with change date | |
| 2024-07-30 | AA | accounts | Accounts with accounts type full | |
| 2024-03-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-10-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-11 | RESOLUTIONS | resolution | Resolution | |
| 2023-04-11 | MA | incorporation | Memorandum articles | |
| 2023-03-30 | CC04 | change-of-constitution | Statement of companys objects | |
| 2022-11-02 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-10 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Spotted an error, or named here and want to reply? Report it · How we handle corrections